FREDERICK, MD--(Marketwire - November 01, 2011) -
| Highlighted Links |
|
|
BioElectronics Corporation. (OTCQB: BIEL) (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free topical pain devices, today announced that they have filed a patent application Pulsed Electromagnetic Field Device with Adhesive Applicator.
The patent application relates to systems and techniques for applying self-contained electromagnetic device and an adhesive compound to bodily tissue or clothing. The adhesive composition may include therapeutic agents or hot or cold substances to create a temporary sensation of relief while the device continues to provide long term therapy.
“The use of an inexpensive, long-lasting, hypoallergenic adhesive greatly enhances body applications and therapeutic uses of our devices by supporting 24/7 continuous use of our anti-inflammation and tissue healing technology,” commented John Martinez, Director of Engineering.
About BioElectronics Corporation
BioElectronics Corporation is an award-winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see www.bielcorp.com.
FORWARD LOOKING STATEMENTS
This press release contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements that address activities, events or developments that we intend, expect, plan, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on certain assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions and expected future developments. Actual results and the timing of events may differ materially from those contemplated by the forward-looking statements due to a number of factors.
Contact:
Ben Fichter
BioElectronics, Inc.
(301) 874-4890
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
